Evidence map›Paper›PMID 28588007›Full record

Trial reportJournal of medical Internet research2017

A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial.

Titus Josef Brinker, Andreas Dawid Owczarek, Werner Seeger, David Alexander Groneberg, Christian Martin Brieske, Philipp Jansen, Joachim Klode, Ingo Stoffels, Dirk Schadendorf, Benjamin Izar and 2 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Mobile Health Interventions for Adolescent Smoking Prevention: A Scoping Review.Asian Pacific journal of cancer prevention : APJCP · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Titus Josef BrinkerUniversities of Giessen and Marburg Lung Center; Member of the German Center for Lung Research (DZL), Department of Internal Medicine, Justus-Liebig-University of Giessen, Giessen, Germany.ORCID 0000-0002-3620-5919
Andreas Dawid OwczarekUniversities of Giessen and Marburg Lung Center; Member of the German Center for Lung Research (DZL), Department of Internal Medicine, Justus-Liebig-University of Giessen, Giessen, Germany.ORCID 0000-0001-6765-3557
Werner SeegerUniversities of Giessen and Marburg Lung Center; Member of the German Center for Lung Research (DZL), Department of Internal Medicine, Justus-Liebig-University of Giessen, Giessen, Germany.ORCID 0000-0003-1946-0894
David Alexander GronebergInstitute of Occupational Medicine, Social Medicine and Environmental Medicine, Goethe-University, Frankfurt am Main, Germany.ORCID 0000-0002-0163-0413
Christian Martin BrieskeEssen University Hospital, Department of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-8528-6022
Philipp JansenEssen University Hospital, Department of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0003-3139-2118
Joachim KlodeEssen University Hospital, Department of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0001-9239-7014
Ingo StoffelsEssen University Hospital, Department of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0003-0111-1303
Dirk SchadendorfEssen University Hospital, Department of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0003-3524-7858
Benjamin IzarDana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA, United States.ORCID 0000-0003-0807-4461
Fabian Norbert FriesSaarland University Medical Center and Saarland University Faculty of Medicine, Department of Ophthalmology, University of Homburg, Homburg, Germany.ORCID 0000-0002-8526-4712
Felix Johannes HofmannUniversities of Giessen and Marburg Lung Center; Member of the German Center for Lung Research (DZL), Department of Internal Medicine, Justus-Liebig-University of Giessen, Giessen, Germany.ORCID 0000-0002-5395-3652
German Cancer Research Center · DEJustus-Liebig-Universität Gießen · DEGoethe University Frankfurt · DEDana-Farber Cancer Institute · USSaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMore than 8.5 million Germans suffer from chronic diseases attributable to smoking. Education Against Tobacco (EAT) is a multinational network of medical students who volunteer for school-based prevention in the classroom setting, amongst other activities. EAT has been implemented in 28 medical schools in Germany and is present in 13 additional countries around the globe. A recent quasi-experimental study showed significant short-term smoking cessation effects on 11-to-15-year-old adolescents.

objectiveThe aim of this study was to provide the first randomized long-term evaluation of the optimized 2014 EAT curriculum involving a photoaging software for its effectiveness in reducing the smoking prevalence among 11-to-15-year-old pupils in German secondary schools.

methodsA randomized controlled trial was undertaken with 1504 adolescents from 9 German secondary schools, aged 11-15 years in grades 6-8, of which 718 (47.74%) were identifiable for the prospective sample at the 12-month follow-up. The experimental study design included measurements at baseline (t1), 6 months (t2), and 12 months postintervention (t3), via questionnaire. The study groups consisted of 40 randomized classes that received the standardized EAT intervention (two medical student-led interactive modules taking 120 minutes total) and 34 control classes within the same schools (no intervention). The primary endpoint was the difference in smoking prevalence from t1 to t3 in the control group versus the difference from t1 to t3 in the intervention group. The differences in smoking behavior (smoking onset, quitting) between the two groups, as well as gender-specific effects, were studied as secondary outcomes.

resultsNone of the effects were significant due to a high loss-to-follow-up effect (52.26%, 786/1504). From baseline to the two follow-up time points, the prevalence of smoking increased from 3.1% to 5.2% to 7.2% in the control group and from 3.0% to 5.4% to 5.8% in the intervention group (number needed to treat [NNT]=68). Notable differences were observed between the groups for the female gender (4.2% to 9.5% for control vs 4.0% to 5.2% for intervention; NNT=24 for females vs NNT=207 for males), low educational background (7.3% to 12% for control vs 6.1% to 8.7% for intervention; NNT=30), and migrational background (students who claimed that at least one parent was not born in Germany) at the 12-month follow-up. The intervention appears to prevent smoking onset (NNT=63) but does not appear to initiate quitting.

conclusionsThe intervention appears to prevent smoking, especially in females and students with a low educational background.

Indexed as

AdolescentChildFemaleGermanyHumansMaleNicotianaProspective StudiesResearch DesignSchool Health ServicesSchoolsSmokingSmoking CessationSmoking PreventionStudents, MedicalSurveys and Questionnairesadolescentsmedical studentsschool-based preventionsecondary schoolssmoking cessationtobacco prevention

Identifiers

PMID28588007
PMCPMC5478798
OpenAlexW2624611165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.